Glenmark Pharmaceuticals Ltd. Reaches All-Time High Price, Reflecting Strong Market Performance
Glenmark Pharmaceuticals Ltd. has achieved an all-time high price of Rs.1800 on October 10th, 2024, showcasing its strong performance in the market. The stock has outperformed the Sensex with a 1-year performance of 126.56%. Despite some volatility, the stock remains above its moving averages, indicating a positive trend.
Glenmark Pharmaceuticals Ltd., a largecap pharmaceutical company, has reached an all-time high price of Rs.1800 on October 10th, 2024. This news comes as the stock has been performing well in the market, with a 1-year performance of 126.56% compared to the Sensex's 23.55% performance.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for Glenmark Pharmaceuticals Ltd. is 'Hold'. The stock has also underperformed the sector by -0.49% today, after a 4-day consecutive gain.
The stock has been trading in a narrow range of Rs.13 and has shown high volatility with an intraday volatility of 269.57% (calculated from weighted average price). However, Glenmark Pharma is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
Glenmark Pharmaceuticals Ltd. is a leading player in the pharmaceutical industry, with a large market cap. Its recent all-time high price is a testament to its strong performance and growth in the market. This news is sure to be welcomed by investors and stakeholders of the company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
